Annual report pursuant to Section 13 and 15(d)

NATURE OF OPERATIONS AND SIGNIFICANT ACCOUNTING POLICIES (Details 7)

v2.4.1.9
NATURE OF OPERATIONS AND SIGNIFICANT ACCOUNTING POLICIES (Details 7) (USD $)
In Thousands, except Per Share data, unless otherwise specified
0 Months Ended 12 Months Ended 0 Months Ended
Dec. 01, 2014
Sep. 19, 2014
Aug. 29, 2014
Jun. 26, 2014
Jun. 02, 2014
Apr. 07, 2014
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Aug. 25, 2014
Strategic Alliance and Formation of China Joint Venture [Line Items]                    
Payments of Dividends $ 1,871us-gaap_PaymentsOfDividends $ 28,501us-gaap_PaymentsOfDividends $ 1,619us-gaap_PaymentsOfDividends   $ 1,619us-gaap_PaymentsOfDividends $ 1,618us-gaap_PaymentsOfDividends $ 35,228us-gaap_PaymentsOfDividends $ 30,419us-gaap_PaymentsOfDividends $ 2,349us-gaap_PaymentsOfDividends  
Premium to Entity Average Stock Price for the Trailing Thirty Day Period       10.00%natr_PremiumToEntityAverageStockPriceForTrailingThirtyDayPeriod            
Fosun Pharma [Member]                    
Strategic Alliance and Formation of China Joint Venture [Line Items]                    
Shares, Issued                   2,855us-gaap_SharesIssued
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= natr_FosunPharmaMember
Share Price                   $ 16.19us-gaap_SharePrice
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= natr_FosunPharmaMember
Period of Time to Measure Premium of Entity Common Stock       30 days            
Related Party Ownership Percentage After Common Stock Purchase                   15.00%natr_RelatedPartyOwnershipPercentageAfterCommonStockPurchase
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= natr_FosunPharmaMember
Common Stock                    
Strategic Alliance and Formation of China Joint Venture [Line Items]                    
Dividends Payable, Amount Per Share                   $ 1.50us-gaap_DividendsPayableAmountPerShare
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember
Dividends payable to shareholders                   28,501natr_DividendsPayableToShareholders
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember
Common Stock | Fosun Pharma [Member]                    
Strategic Alliance and Formation of China Joint Venture [Line Items]                    
Proceeds from Issuance of Private Placement                   44,795us-gaap_ProceedsFromIssuanceOfPrivatePlacement
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= natr_FosunPharmaMember
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember
China Joint Venture [Member]                    
Strategic Alliance and Formation of China Joint Venture [Line Items]                    
Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions                   80.00%us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions
/ dei_LegalEntityAxis
= natr_ChinaJointVentureMember
Initial Capitalization Amount                   20,000natr_InitialCapitalizationAmount
/ dei_LegalEntityAxis
= natr_ChinaJointVentureMember
China Joint Venture [Member] | Fosun Pharma [Member]                    
Strategic Alliance and Formation of China Joint Venture [Line Items]                    
Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions                   20.00%us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions
/ dei_LegalEntityAxis
= natr_ChinaJointVentureMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= natr_FosunPharmaMember
Initial Capitalization Amount                   $ 16,000natr_InitialCapitalizationAmount
/ dei_LegalEntityAxis
= natr_ChinaJointVentureMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= natr_FosunPharmaMember
Number of Board of Directors Initially Appointed                   1natr_NumberOfBoardOfDirectorsInitiallyAppointed
/ dei_LegalEntityAxis
= natr_ChinaJointVentureMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= natr_FosunPharmaMember